Krysiak Robert, Okopień Bogusław, Herman Zbigniew Stanisław
Department of Clinical Pharmacology, Silesian Medical University, Poland.
Pol Merkur Lekarski. 2006 Dec;21(126):573-8.
The term subclinical thyroid disorders apply to patients who have an abnormal serum thyroid-stimulating hormone (TSH) concentration but thyroxine and triiodothyronine levels within their reference ranges. Subclinical hypothyroidism occurs in 4% to 10% of the general population, and is especially prevalent in elderly women. Depending on the study, subclinical hyperthyroidism has been found in 0.6-16 % of the population. Potential risks of subclinical hypothyroidism include progression to overt hypothyroidism, dyslipidemia, cardiovascular complications, and neurological and neuropsychiatric effects. In turn, subclinical hyperthyroidism represents a considerable risk factor for atrial fibrillation in the elderly and for postmenopausal osteoporosis. Treatment of subclinical thyroid disorders is controversial. In this paper, we discuss the prevalence, aetiology, clinical presentation, diagnosis, natural history, and potential pathophysiological consequences of subclinical hypothyroidism and subclinical hyperthyroidism. We also provide some screening and management recommendations.
亚临床甲状腺疾病这一术语适用于血清促甲状腺激素(TSH)浓度异常但甲状腺素和三碘甲状腺原氨酸水平在参考范围内的患者。亚临床甲状腺功能减退在普通人群中的发生率为4%至10%,在老年女性中尤为普遍。根据研究,亚临床甲状腺功能亢进在人群中的发现率为0.6%至16%。亚临床甲状腺功能减退的潜在风险包括进展为显性甲状腺功能减退、血脂异常、心血管并发症以及神经和神经精神方面的影响。反过来,亚临床甲状腺功能亢进是老年人房颤和绝经后骨质疏松的一个重要危险因素。亚临床甲状腺疾病的治疗存在争议。在本文中,我们讨论了亚临床甲状腺功能减退和亚临床甲状腺功能亢进的患病率、病因、临床表现、诊断、自然病程以及潜在的病理生理后果。我们还提供了一些筛查和管理建议。